Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?

Mov Disord. 2022 Aug;37(8):1779-1781. doi: 10.1002/mds.29132. Epub 2022 Jul 6.

Authors

Affiliations

¹ Petersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Gatchina, Russia.
² First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.
³ Federal State Budgetary Institution "Research Centre for Medical Genetics", Moscow, Russia.
⁴ N.P. Bechtereva Institute of the Human Brain, RAS, St. Petersburg, Russia.

PMID: 35792565
DOI: 10.1002/mds.29132

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Gaucher Disease*
Glucosylceramidase / genetics
Humans
Mutation / genetics
Parkinson Disease* / diagnosis
Parkinson Disease* / genetics
alpha-Synuclein / genetics

Substances

Biomarkers
alpha-Synuclein
Glucosylceramidase